Glenmark Pharmaceuticals Ltd. - GLENMARK, 532296 corporate action history

Ex-Date	Bonus Ratio	Record Date
04 Mar 2005	1:1	-

Ex-Date	Old FV	New FV	Record Date
10 Sep 2007	2	1	-
23 Oct 2003	10	2	31 Oct 2003

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
15 Sep 2025	2.50	FINAL	15 Sep 2025	Equity Share
13 Sep 2024	2.50	FINAL	-	Equity Share
18 Sep 2023	2.50	FINAL	-	Equity Share
12 Sep 2022	2.50	FINAL	-	Equity Share
08 Sep 2021	2.50	FINAL	-	Equity Share
17 Sep 2020	2.50	FINAL	-	Equity Share
19 Sep 2019	2.00	FINAL	-	Equity Share
19 Sep 2018	2.00	FINAL	-	Equity Share
20 Sep 2017	2.00	FINAL	-	Equity Share
03 Aug 2016	2.00	FINAL	-	Equity Share
10 Sep 2015	2.00	FINAL	-	Equity Share
10 Jul 2014	2.00	FINAL	-	Equity Share
18 Jul 2013	2.00	FINAL	-	Equity Share
19 Jul 2012	2.00	FINAL	-	Equity Share
28 Jul 2011	0.40	FINAL	-	Equity Share
16 Sep 2010	0.40	FINAL	-	Equity Share
10 Sep 2009	0.40	FINAL	-	Equity Share
07 Nov 2007	0.70	INTERIM	08 Nov 2007	Equity Share
04 Jan 2007	0.80	INTERIM	05 Jan 2007	Equity Share
07 Feb 2006	0.70	INTERIM	09 Feb 2006	Equity Share
29 Apr 2005	0.70	INTERIM	02 May 2005	Equity Share
31 Mar 2004	1.30	INTERIM	03 Apr 2004	Equity Share
10 Jun 2003	6.50	INTERIM	-	Equity Share
12 Sep 2002	6.00	FINAL	-	Equity Share
03 Sep 2001	4.00	FINAL	-	Equity Share

Ex-Date	Purpose	Notes
14 Aug 2025	Quarterly Results	-
23 May 2025	Audited Results & Final Dividend	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
14 Aug 2024	Quarterly Results	-
24 May 2024	Audited Results & Final Dividend	-
14 Feb 2024	Quarterly Results	-
10 Nov 2023	Quarterly Results	-
11 Aug 2023	Quarterly Results	-
19 May 2023	Audited Results & Final Dividend	-